Highly Conserve Sequences in Envelope, Nucleoprotein and RNA-Dependent RNA Polymerase of SARS-CoV-2 in Nasopharyngeal Samples of the COVID-19 Patients; a Diagnostic Target for Further Studies
Journal of Cellular & Molecular Anesthesia,
Vol. 7 No. 2 (2022),
5 Khordad 2022
,
Page 78-83
https://doi.org/10.22037/jcma.v7i2.36963
Abstract
Background: The etiological agent of COVID-19 is SARS-CoV-2. Conversional molecular methods used for detection of virus in COVID-19 infected patient. This study aimed to investigate the presence of escape mutations from molecular detection on SARS-CoV-2 targeted genes, which indicates importance of mutations in false negative PCR test results in detection of virus in clinical specimens of patients with COVID-19.
Material and Method: The 20 nasopharyngeal swabs samples collected from COVID-19 confirmed patients. The SARS-CoV-2 E, nsp12 and N genetic regions Amplified by RT-PCR assay. PCR products sequenced using the Sanger sequencing method and Multiple sequence alignment for the assessment of the polymorphism and mutations preformed using MEGA X software and Maximum likelihood method for the phylogenetic assessment.
Result: Among all COVID-19 cases 60% and 40% were male and female, respectively. The MSA showed high conservation between all of the evaluated samples and VOCs in all N, E and nsp12 genes. Also, the phylogenetic evaluation by Maximum likelihood method reported high similarity between all SARS-CoV-2 sequenced samples, VOCs and Wuhan reference sequence in evaluated region.
Conclusion: Our study results approved the relatively conserved suitability of the E, N and RdRp-gene regions without any diversity, therefore, making them perfect candidates for first-line screening.
- SARS-CoV-2
- COVID-19
- Mutation
- Phylogenetic
How to Cite
References
Tian F, Tong B, Sun L, Shi S, Zheng B, Wang Z, et al. N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2. Elife. 2021;10:e69091.
Soltani S. The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43. Eur Rev Med Pharmacol Sci. 2020;24(12):6484-5.
Gallaher WR. A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2. Arch Virol. 2020;165(10):2341-8.
Latini A, Agolini E, Novelli A, Borgiani P, Giannini R, Gravina P, et al. COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells. Genes. 2020;11(9):1010.
Pourhossein B, Dabbagh A, Fazeli M. Insights into the SARS-CoV2 Outbreak; the great global challenge: A mini review. Journal of Cellular and Molecular Anesthesia. 2020;5(1):23-6.
Ciotti M, Maurici M, Pieri M, Andreoni M, Bernardini S. Performance of a rapid antigen test in the diagnosis of SARS‐CoV‐2 infection. J Med Virol. 2021;93(5):2988-91.
Shen M, Zhou Y, Ye J, Al-Maskri AAA, Kang Y, Zeng S, et al. Recent advances and perspectives of nucleic acid detection for coronavirus. J Pharm Anal. 2020;10(2):97-101.
Noh JY, Yoon S-W, Kim D-J, Lee M-S, Kim J-H, Na W, et al. Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR. Arch Virol. 2017;162(6):1617-23.
van Kasteren PB, van Der Veer B, van den Brink S, Wijsman L, de Jonge J, van den Brandt A, et al. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol. 2020;128:104412.
Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn. 2020;20(5):453-4.
Mo X, Qin W, Fu Q, Guan M. Understanding the influence factors in viral nucleic acid test of 2019 novel coronavirus. Chin J Lab Med. 2020;43(3).
The World Health Organization. Diagnostic detection of 2019-nCoV by real-time RT-PCR. https://www.who.int/docs/default-source/coronaviruse/whoinhouseassays.2020
Saha O, Islam I, Shatadru RN, Rakhi NN, Hossain MS, Rahaman MM. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh. Virus genes. 2021:1-13.
Mollaei HR, Afshar AA, Kalantar-Neyestanaki D, Fazlalipour M, Aflatoonian B. Comparison five primer sets from different genome region of COVID-19 for detection of virus infection by conventional RT-PCR. Iran J Microbiol. 2020;12(3):185.
Cagliani R, Forni D, Clerici M, Sironi M. Computational inference of selection underlying the evolution of the novel coronavirus, severe acute respiratory syndrome coronavirus 2. Virol J. 2020;94(12):e00411-20.
van Dorp L, Acman M, Richard D, Shaw LP, Ford CE, Ormond L, et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 2020;83:104351.
Nalla AK, Casto AM, Huang M-LW, Perchetti GA, Sampoleo R, Shrestha L, et al. Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit. J Clin Microbiol. 2020;58(6):e00557-20.
Islam MR, Hoque MN, Rahman MS, Alam AS, Akther M, Puspo JA, et al. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity. Sci Rep. 2020;10(1):1-9.
Poterico JA, Mestanza O. Genetic variants and source of introduction of SARS‐CoV‐2 in South America. J Med Virol. 2020;92(10):2139-45.
Ramírez JD, Muñoz M, Hernández C, Flórez C, Gomez S, Rico A, et al. Genetic diversity among SARS-CoV2 strains in South America may impact performance of molecular detection. Pathogens. 2020;9(7):580.
Júnior JVJS, Merchioratto I, de Oliveira PSB, Lopes TRR, Brites PC, de Oliveira EM, et al. End-point RT-PCR: a potential alternative for diagnosing coronavirus disease 2019 (COVID-19). J Virol Methods. 2021;288:114007.
Eftekhari A, Alipour M, Chodari L, Maleki Dizaj S, Ardalan M, Samiei M, et al. A comprehensive review of detection methods for SARS-CoV-2. Microorganisms. 2021;9(2):232.
Miller S, Chiu C, Rodino KG, Miller MB. Point-counterpoint: should we be performing metagenomic next-generation sequencing for infectious disease diagnosis in the clinical laboratory? J Clin Microbiol. 2020;58(3):e01739-19.
Sidiq Z, Hanif M, Dwivedi KK, Chopra K. Benefits and limitations of serological assays in COVID-19 infection. Indian J Tuberc. 2020;67(4):S163-S6.
- Abstract Viewed: 273 times
- PDF Downloaded: 202 times